Axim Biotechnologies, Inc. SEC filings AXIM
Axim Biotechnologies, Inc. has 306 filings in SEC EDGAR's recent list, going back to Mar 10, 2011. Its latest annual report, Form 10-K, was filed on Apr 16, 2024 for the period ended Dec 31, 2023. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2024, covering the quarter ended Jun 30, 2024. The most recent current report (Form 8-K) was filed on Oct 15, 2024 (change in control, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 15-12G | Deregistration | Dec 6, 2024 | — |
| NT 10-Q | Axim biotechnologies, inc._form nt 10-q | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Change in control, Officer or director change
|
Oct 15, 2024 | Oct 9, 2024 |
| 10-Q | Quarterly report | Aug 19, 2024 | Jun 30, 2024 |
| NT 10-Q | Axim biotechnologies form 12b-25 | Aug 13, 2024 | Jun 30, 2024 |
| 10-Q/A | Amended quarterly report | May 22, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | May 20, 2024 | Mar 31, 2024 |
| NT 10-Q | Axim biotechnologies form 12b-25 | May 15, 2024 | Mar 31, 2024 |
| 10-K | Annual report | Apr 16, 2024 | Dec 31, 2023 |
| NT 10-K | Axim biotechnologies, inc. - nt 10k | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 21, 2024 | Mar 15, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 13, 2024 | Feb 7, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 28, 2023 | Dec 26, 2023 |
| 10-Q | Quarterly report | Nov 20, 2023 | Sep 30, 2023 |
| NT 10-Q | Axim biotechnologies, inc._form nt 10-q | Nov 14, 2023 | Sep 30, 2023 |
| DEF 14C | Information statement | Sep 21, 2023 | Sep 21, 2023 |
| PRE 14C | Schedule 14c information | Aug 31, 2023 | Aug 30, 2023 |
| 10-Q | Quarterly report | Aug 21, 2023 | Jun 30, 2023 |
| NT 10-Q | Axim biotechnologies, inc._form nt 10-q | Aug 14, 2023 | Jun 30, 2023 |
| EFFECT | Filing | Jun 9, 2023 | — |
| CORRESP | Letter to the SEC | Jun 7, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2023 | — |
| S-1 | Registration statement | Jun 2, 2023 | — |
| 8-K |
Current report
Material agreement
|
Jun 2, 2023 | Jun 1, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
May 30, 2023 | May 23, 2023 |
| 8-K |
Current report
Officer or director change
|
May 25, 2023 | May 23, 2023 |
| 10-Q | Quarterly report | May 22, 2023 | Mar 31, 2023 |
| NT 10-Q | Axim biotechnologies, inc._form nt 10-q | May 15, 2023 | Mar 31, 2023 |
| 10-K | Annual report | Apr 17, 2023 | Dec 31, 2022 |
| NT 10-K | Axim biotechnologies, inc. - nt 10k | Mar 31, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Jan 27, 2023 | Jan 23, 2023 |
| 10-Q/A | Amended quarterly report | Nov 15, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 19, 2022 | Sep 15, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 29, 2022 | Aug 29, 2022 |
| 10-Q | Quarterly report | Aug 16, 2022 | Jun 30, 2022 |
| NT 10-Q | Axim biotechnologies, inc. form nt 10-q | Aug 16, 2022 | Jun 30, 2022 |
| EFFECT | Filing | Aug 4, 2022 | — |
| CORRESP | Letter to the SEC | Aug 2, 2022 | — |
| S-1/A | Amended registration statement | Aug 2, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2022 | — |
| S-1 | Registration statement | Jul 25, 2022 | — |
| S-8 | Employee stock plan registration | Jun 14, 2022 | — |
| 10-Q | Quarterly report | May 23, 2022 | Mar 31, 2022 |
| NT 10-Q | Axim biotechnologies, inc. form nt 10-q | May 17, 2022 | Mar 31, 2022 |
| 10-K/A | Amended annual report | Apr 19, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Apr 15, 2022 | Dec 31, 2021 |
| NT 10-K | Axim biotechnologies, inc. form 12b-25 | Mar 31, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
Mar 9, 2022 | Mar 7, 2022 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
|
Feb 16, 2022 | Feb 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 12, 2022 | Jan 6, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 7, 2022 | Jan 4, 2022 |
| 10-Q | Quarterly report | Nov 22, 2021 | Sep 30, 2021 |
| NT 10-Q | Axim biotechnologies, inc. form nt 10-q | Nov 15, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 23, 2021 | Jun 30, 2021 |
| NT 10-Q | Axim biotechnologies, inc. form nt 10-q | Aug 16, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 4, 2021 | Aug 3, 2021 |
| EFFECT | Filing | Jun 22, 2021 | — |
| CORRESP | Letter to the SEC | Jun 21, 2021 | — |
| S-1/A | Amended registration statement | Jun 9, 2021 | — |
| 10-Q/A | Amended quarterly report | Jun 2, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | May 24, 2021 | Mar 31, 2021 |
| UPLOAD | Letter from the SEC | May 19, 2021 | — |
| NT 10-Q | Form nt 10-q notice of late quarterly filing | May 14, 2021 | Mar 31, 2021 |
| S-1 | Registration statement | May 14, 2021 | — |
| 8-K |
Current report
Material agreement
|
May 14, 2021 | May 14, 2021 |
| 10-K/A | Amended annual report | Apr 26, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Apr 15, 2021 | Dec 31, 2020 |
| NT 10-K | Form 12b-25 notice of late filing | Mar 30, 2021 | Dec 31, 2020 |
| 10-Q/A | Amended quarterly report | Nov 27, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Nov 20, 2020 | Sep 30, 2020 |
| NT 10-Q | Form 12b-25 notice of late filing | Nov 16, 2020 | Sep 30, 2020 |
| 10-Q/A | Amended quarterly report | Aug 18, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | Aug 14, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Jul 24, 2020 | Jul 21, 2020 |
| 10-Q/A | Amended quarterly report | Jul 2, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Jun 29, 2020 | Mar 31, 2020 |
| NT 10-Q | Form 12b25 extension | Jun 29, 2020 | Mar 31, 2020 |
| D | Filing | Jun 15, 2020 | — |
| 8-K/A | Amended current report | May 29, 2020 | May 14, 2020 |
| 10-K/A | Amended annual report | May 20, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Other events
|
May 14, 2020 | May 14, 2020 |
| 10-K | Annual report | May 14, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 13, 2020 | May 13, 2020 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Officer or director change
|
May 12, 2020 | May 6, 2020 |
| 8-K |
Current report
Other events
|
Mar 27, 2020 | Mar 27, 2020 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
|
Mar 19, 2020 | Mar 17, 2020 |
| UPLOAD | Letter from the SEC | Jan 10, 2020 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 8, 2020 | Jan 3, 2020 |
| CORRESP | Letter to the SEC | Dec 23, 2019 | — |
| 8-K |
Current report
Material agreement
|
Dec 17, 2019 | Dec 16, 2019 |
| 424B5 | Prospectus supplement | Dec 17, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2019 | — |
| 10-Q | Quarterly report | Nov 14, 2019 | Sep 30, 2019 |
| 10-K/A | Amended annual report | Oct 30, 2019 | Dec 31, 2018 |
| CORRESP | Letter to the SEC | Oct 29, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2019 | — |
| 10-Q | Quarterly report | Aug 14, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 9, 2019 | Jul 2, 2019 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 4, 2019 | May 31, 2019 |
| 10-Q | Quarterly report | May 15, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 23, 2019 | Apr 19, 2019 |
| 10-K | Annual report | Apr 8, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 4, 2019 | Apr 2, 2019 |
| NT 10-K | Form nt 10-k notice of late filing | Apr 1, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Change in control
|
Feb 26, 2019 | Feb 20, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 15, 2019 | Jan 15, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 8, 2019 | Jan 2, 2019 |
| 8-K |
Current report
Material agreement
|
Dec 7, 2018 | Nov 30, 2018 |
| 10-Q | Quarterly report | Nov 14, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 13, 2018 | Sep 10, 2018 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 27, 2018 | Aug 21, 2018 |
| 10-Q/A | Amended quarterly report | Aug 17, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | Aug 14, 2018 | Jun 30, 2018 |
| D | Filing | May 21, 2018 | — |
| 10-Q/A | Amended quarterly report | May 18, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | May 15, 2018 | Mar 31, 2018 |
| 8-K |
Current report
Material agreement
|
May 11, 2018 | May 7, 2018 |
| 8-K |
Current report
Material agreement
|
Apr 18, 2018 | Mar 30, 2018 |
| 424B5 | Prospectus supplement | Apr 18, 2018 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 5, 2018 | Apr 5, 2018 |
| 10-K | Annual report | Mar 15, 2018 | Dec 31, 2017 |
| 10-Q | Quarterly report | Nov 20, 2017 | Sep 30, 2017 |
| NT 10-Q | Form nt 10-q notice of late quarterly filing | Nov 15, 2017 | Sep 30, 2017 |
| EFFECT | Filing | Sep 14, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 14, 2017 | — |
| 10-Q/A | Amended quarterly report | Sep 14, 2017 | Jun 30, 2017 |
| 10-Q/A | Amended quarterly report | Sep 14, 2017 | Mar 31, 2017 |
| 10-K/A | Amended annual report | Sep 14, 2017 | Dec 31, 2016 |
| UPLOAD | Letter from the SEC | Sep 14, 2017 | — |
| CORRESP | Letter to the SEC | Sep 11, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 6, 2017 | — |
| S-3 | Shelf registration | Aug 24, 2017 | — |
| 10-Q | Quarterly report | Aug 21, 2017 | Jun 30, 2017 |
| NT 10-Q | Form nt 10q notice of late quarterly filing | Aug 14, 2017 | Jun 30, 2017 |
| 8-K/A |
Amended current report
Material agreement, New debt, Unregistered share sale
|
Jun 26, 2017 | Jun 12, 2017 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 16, 2017 | Jun 12, 2017 |
| 10-Q | Quarterly report | May 22, 2017 | Mar 31, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
May 17, 2017 | May 15, 2017 |
| NT 10-Q | Form12b25 notice of late filing | May 16, 2017 | Mar 31, 2017 |
| 8-K |
Current report
Other events
|
May 15, 2017 | May 9, 2017 |
| 10-K/A | Amended annual report | Apr 19, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Apr 17, 2017 | Dec 31, 2016 |
| NT 10-K | Form12b25 notice of late filing | Mar 31, 2017 | Dec 31, 2016 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 28, 2017 | Mar 28, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 22, 2017 | Mar 21, 2017 |
| 8-K |
Current report
Other events
|
Jan 19, 2017 | Jan 18, 2017 |
| 8-K |
Current report
Other events
|
Jan 10, 2017 | Dec 20, 2016 |
| 8-K |
Current report
Other events
|
Dec 30, 2016 | Dec 20, 2016 |
| 8-K |
Current report
Other events
|
Dec 13, 2016 | Dec 7, 2016 |
| 10-Q/A | Amended quarterly report | Nov 30, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Nov 21, 2016 | Sep 30, 2016 |
| NT 10-Q | Form12b25 notice of late filing | Nov 14, 2016 | Sep 30, 2016 |
| 10-Q/A | Amended quarterly report | Aug 25, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | Aug 22, 2016 | Jun 30, 2016 |
| 8-K |
Current report
Officer or director change
|
Aug 22, 2016 | Jun 29, 2016 |
| NT 10-Q | Form12b25 notice of late filing | Aug 16, 2016 | Jun 30, 2016 |
| 10-Q/A | Amended quarterly report | May 26, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | May 23, 2016 | Mar 31, 2016 |
| NT 10-Q | Form 12b-25 | May 13, 2016 | Mar 31, 2016 |
| 10-K/A | Amended annual report | Apr 18, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Apr 14, 2016 | Dec 31, 2015 |
| NT 10-K | Filing | Mar 30, 2016 | Dec 31, 2015 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 19, 2016 | Feb 18, 2016 |
| 8-K |
Current report
Other events
|
Feb 8, 2016 | Jan 25, 2016 |
| 10-Q | Quarterly report | Nov 23, 2015 | Sep 30, 2015 |
| NT 10-Q | Form 12b-25 | Nov 16, 2015 | Sep 30, 2015 |
| 8-K |
Current report
Other events
|
Sep 1, 2015 | Aug 26, 2015 |
| 10-Q/A | Amended quarterly report | Aug 27, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | Aug 19, 2015 | Jun 30, 2015 |
| NT 10-Q | Filing | Aug 14, 2015 | Jun 30, 2015 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 6, 2015 | Jul 31, 2015 |
| 8-K |
Current report
Other events
|
Jun 18, 2015 | Jun 18, 2015 |
| S-8 | Employee stock plan registration | May 29, 2015 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
May 14, 2015 | May 11, 2015 |
| 10-Q | Quarterly report | May 13, 2015 | Mar 31, 2015 |
| 10-K | Annual report | Apr 14, 2015 | Dec 31, 2014 |
| NT 10-K | Form 12b-25 | Mar 31, 2015 | Dec 31, 2014 |
| 8-K |
Current report
Other events
|
Mar 24, 2015 | Mar 20, 2015 |
| 8-K |
Current report
Other events
|
Jan 28, 2015 | Dec 11, 2014 |
| 8-K |
Current report
Material agreement
|
Nov 28, 2014 | Nov 25, 2014 |
| 10-Q | Quarterly report | Nov 14, 2014 | Sep 30, 2014 |
| 8-K |
Current report
Other events
|
Nov 6, 2014 | Oct 14, 2014 |
| D | Filing | Oct 23, 2014 | — |
| 10-Q/A | Amended quarterly report | Aug 26, 2014 | Jun 30, 2014 |
| 10-Q | Quarterly report | Aug 19, 2014 | Jun 30, 2014 |
| NT 10-Q | Form 12b-25 (6-30-14) | Aug 13, 2014 | Jun 30, 2014 |
| 8-K |
Current report
Auditor change
|
Jul 21, 2014 | Jul 16, 2014 |
| DEF 14C | Information statement | Jul 7, 2014 | Jul 7, 2014 |
| UPLOAD | Letter from the SEC | Jul 7, 2014 | — |
| CORRESP | Letter to the SEC | Jun 30, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2014 | — |
| 10-Q/A | Amended quarterly report | Jun 18, 2014 | Mar 31, 2014 |
| PRER14C | Schedule 14c | Jun 16, 2014 | — |
| CORRESP | Letter to the SEC | Jun 13, 2014 | — |
| 8-K/A |
Amended current report
Change in control
|
Jun 9, 2014 | Mar 17, 2014 |
| CORRESP | Letter to the SEC | Jun 9, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 5, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2014 | — |
| CORRESP | Letter to the SEC | May 29, 2014 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AXIM (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1514946
- Former names
- AXIM INTERNATIONAL INC. (until Aug 13, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.